Ropes & Gray Represents Solarea Bio in Series B Financing to Support Launch of Two Medical Food Products
Ropes & Gray represented Solarea Bio, a clinical stage biotechnology developing food-derived microbial-based solutions to aid human health, in a first closing of $15 million in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners, Viking Global Investors, and GG 1978 SICAF SIF. A total of up to $25 million is targeted for this round of financing. The funds will be allocated to the commercial launch of two medical foods designed for the dietary management of bone health and rheumatoid arthritis, respectively. The financing was announced on May 8.
The Ropes & Gray team was led by venture capital & emerging companies partner Brad Flint and venture capital & emerging companies associates Danielle Heinlein and Joe Muller.